In vivo indomethacin treatment causes microglial activation in adult mice

Neurochemical Research

Volumn 25, Issue 3, 2000, Pages 357-362

  Prechel, M Margaret ^a,c   Ding, Charley ^b   Washington, Remy L ^b   Kolodziej, Meghan S ^a   Young, M Rita ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain; Complement receptor; Indomethacin; Mac 1; Microglia; Prostaglandin

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

ANIMALS; CYCLOOXYGENASE INHIBITORS; INDOMETHACIN; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED C57BL; MICROGLIA; PROSTAGLANDINS;

ANIMALIA;

EID: 0034098822     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007588903897     Document Type: Article

References (50)

1. Theele, D. P. and Streit, W. J. 1993. A chronicle of microglial ontogeny. Glia 7:5-8.
2. Ulvestad, E., Williams, K., Bjerkvig, R., Tiekotter, K., Antel, J., and Matre, R. 1994. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukoc. Biol. 56:732-740.
3. Sheng, J. G., Ito, K., Skinner, R. D., Mrak, R. E., Rovnaghi, C. R., Van Eldik, L. J., and Griffin, S. T. 1996. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17:761-766.
4. Hull, M., Fiebich, B. L., Lieb, K., Strauss, S., Berger, M., Volk, B., and Bauer, J. 1996. Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options. Neurobiol. Aging 17:795-800.
5. Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., and Wolf-Klein, G. 1991. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 129:318-320.
6. Colton, C. A. 1994. Microglial oxyradical production: causes and consequences. Neuropath. & Applied Neurobiol. 20:175-216.
7. Cotman, C. W., Tenner, A. J., and Cummings, B. J. 1996. β-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging 17:723-731.
8. Kreutzberg, G. W. 1997. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312-318.
9. Patterson, P. H. 1995. Cytokines in Alzheimer's disease and multiple schlerosis. Curr. Opin. Neurobiol. 5:642-646.
10. Cotter, R. L., Burke, W. J., Thomas, V. S., Potter, J. F., Zheng J., and Gendelman, H. E. 1999. Insights into the neurodegenerative process of Alzheimer's disease; a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J. Leukoc. Biol. 65:416-427.
11. McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., and McGeer, E. G. 1993. Microglia in degenerative neurological disease. Glia 7:84-92.
12. Griffin, W. S. T., Sheng, J. G., Roberts, G. W., and Mrak, R. E. 1995. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol Exp. Neurol. 54:276-281.
13. 2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:111-114.
14. Kalaria, R. N., Harshbarger-Kelly, D. L., Cohen, D. L., and Premkumar, D. R. D. 1996. Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiol. Aging 17: 687-693.
15. Eikelenboom, P. and Veerhuis, R. 1996. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 17:673-680.
16. McGeer, P. L. and McGeer, E. G. 1999. Inflammation of the brain in Alzheimer's disease: implications for therapy. J. Leukoc. Biol. 65:409-415.
17. Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, M. D., Roberts, G. W., and Mrak, R. E. 1998. Glial-Neuronal interactions in Alzheimer's Disease: The potential role of a 'cytokine cycle' in disease progression. Brain Path. 8:65-72.
18. Zicari, A., Lipari, M., Di Renzo, L., Salerno, A., and Pontieri, G. M. 1995. Stimulation of macrophages with IFN gamma or TNF alpha shuts off the suppressive effect played by PGE2. Int. J. Immunopharmacol. 17:779-786.
19. Zhong, W. W., Burke, P. A., Drotar, M. E., Chavali, S. R., and Forse, R. A. 1995. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunol. 84:446-452.
20. Young, M. R. I. 1994. Eicosanoids and the immunology of cancer. Cancer and Metastasis Rev. 13:337-348.
21. McGeer, P. L., Akiyama, H., Itagaki, S., and McGeer, E. G. 1989. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:516-527.
22. Graeber, M. B., Streit, W. J., and Kreutzberg, G. W. 1988. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res. 21:18-24.
23. Streit, W. J., Graeber, M. B., and Kreutzberg, G. W. 1988. Functional plasticity of microglia: a review. Glia 1:301-307.
24. Bannwarth, B., Netter, P., Pourel, J., Royer, R. J., and Gaucher, A. 1989. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomed. & Pharmacother. 43:121-126.
25. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 231:232-235.
26. Flecknell, P. A. 1996. Laboratory Animal Anesthesia: a practical introduction for research workers and technicians, pp. 144. Academic Press, London.
27. Ye, S. and Johnson, R. W. 1999. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93: 139-148.
28. Streit, W. J. 1996. The role of microglia in neurotoxicity, pp. 3-13, in Aschner, M. and Kimelberg, H. K., (eds.), The role of glia in neurotoxicity, CRC Press, New York.
29. Slepko, N. and Levi, G. 1996. Progressive activation of adult microglial cells in vitro. Glia 16:241-246.
30. O'Banion, M. K. 1999. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 13:45-82.
31. Iglesias, B. M., Cerase, J., Cearcchini, C., Levi, G., and Aloisi, F. 1997. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: Upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E(2) and cyclic AMP-elevating agents. J. Neuroimmunol 72:83-93.
32. Schnyder, J., Dewald, B., and Baggiolini, M. 1981. Effects of cyclooxygenase inhibitors and prostaglandin E2 on macrophage activation in vitro. Prostaglandins 22:411-421.
33. Hutchinson, D. L. and Myers, R. L. 1987. Prostaglandin-mediated suppression of macrophage phagocytosis of Listeria monocytogenes. Cellular Immunol. 110:68-76.
34. Parnham, M. J., Winkelman, J., Hartung, H. P., and Hadding, U. 1984. Regulation of the oxidative burst of macrophages by lipid mediators. Agents & Actions 14:215-226.
35. Metzger, Z., Hoffeld, J. T., and Oppenheim, J. J. 1981. Regulation by PGE2 of the production of oxygen intermediates by LPS-activated macrophages. J. Immunol. 127:1109-1113.
36. Bonta, I. L., Elliott, G. R., Tak, C., and Ben-Efraim, S. 1989. Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is enhanced by endogenous metabolites of lipoxygenase and counteracted by prostaglandin E2. Agents & Actions 26:167-169.
37. D'Acquisto, F., Sautebin, L., Iuvone, T., DiRosa, M., and Carnuccio, R. 1998. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappa B activation in J774 macrophages. FEBS Lett. 440:76-80.
38. Kunkel, S. L., Wiggins, R. C., Chensue, S. W., and Larrick, J. 1986. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Comm. 137:404-410.
39. Kunkel, S. L. and Chensue, S. W. 1985. Arachidonic acid metabolites regulate interleukin-1 production. Biochem. Biophys. Res. Comm. 128:892-897.
40. Breitner, J. C. S. 1996. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging 17:789-794.
41. Aisen, P. S. 1997. Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontology 43:143-149.
42. Mackenzie, I. R. and Munoz, D. G. 1998. Nonsteroidal antiinflammatory drug use and Alzheimer-type pathology in aging. Neurology 50:986-990.
43. Fiebich, B. L., Hull, M., Lieb, K., Schumman, G., Berger, M., and Bauer, J. 1998. Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. J. Neural Transm. Suppl. 54:268-278.
44. de la Torre, J. C. 1997. Cerebromicrovascular pathology in Alzheimer's Disease compared to normal aging. Gerontology 43: 26-43.
45. Stanimirovic, D. B., Shapiro, A., Wong, J., Hutchinson, J., and Durkin, J. 1997. The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion. J. Neuroimmunol. 76:193-205.
46. Stanimirovic, D. B., Wong, J., Shapiro, A., and Durkin, J. P. 1997. Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ishemia-like insults. Acta Neurochir. Suppl. (Wien) 70: 12-16.
47. Caggiano, A. O. and Kraig, R. P. 1998. Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1 beta production in cultured rat microglia. J. Neurochem. 70:2357-2368.
48. Caggiano, A. O. and Kraig, R. P. 1999. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1β production. J. Neurochem. 72:565-575.
49. Aloisi, F., De Simone, R., Columba-Cabezas, S., and Levi, G. 1999. Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia; a regulatory loop controlling microglia pro- and antiinflammatory activities. J. Neurosci. Res. 56:571-580.
50. Thery, C., Dobbertin, A., and Mallat, M. 1994. Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a β-adrenergic agonist. Glia 11:383-386.